• 1. Photo-activated time-dependent color-changeable ultralong organic room temperature phosphorescence by co-doping strategy
  Huiwen Jin,Xue Zhang,Zhimin Ma,Chen Qian,Xiaohua Fu,Zewei Li,Mingxing Chen,Yan Guan,Zhiyong Ma J. Mater. Chem. C 2023 11 11571

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzonitriles
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Professional Introduction to 4-Bromo-2,6-difluorobenzonitrile (CAS No: 123843-67-4)

4-Bromo-2,6-difluorobenzonitrile, with the chemical formula C?H?BrF?N and CAS number 123843-67-4, is a fluorinated aromatic nitrile that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and inflammatory disorders. The presence of both bromine and fluorine substituents on the benzene ring imparts unique electronic and steric properties, making it a valuable building block for medicinal chemists.

The< strong>fluorine atoms in 4-Bromo-2,6-difluorobenzonitrile contribute to its lipophilicity and metabolic stability, which are critical factors in drug design. These properties enhance the compound's bioavailability and prolong its therapeutic effects. Additionally, the< strong>bromine moiety provides a handle for further functionalization via cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, enabling the construction of more complex molecular architectures.

In recent years, there has been a surge in research focused on developing novel therapeutic agents for neurological diseases. 4-Bromo-2,6-difluorobenzonitrile has emerged as a key intermediate in the synthesis of small-molecule inhibitors targeting ion channels and receptors involved in neurodegeneration. For instance, studies have demonstrated its utility in creating potent modulators of NMDA receptors, which play a pivotal role in conditions such as Alzheimer's disease and stroke. The< strong>fluorinated nature of this compound enhances its binding affinity and selectivity, making it an attractive candidate for further development.

The pharmaceutical industry has also explored the use of 4-Bromo-2,6-difluorobenzonitrile in the development of anti-inflammatory agents. Fluorinated nitriles have shown promise in modulating inflammatory pathways by inhibiting key enzymes like cyclooxygenase (COX) and lipoxygenase (LOX). Researchers have leveraged the< strong>bromine-containing scaffold to design molecules that exhibit potent anti-inflammatory activity with improved pharmacokinetic profiles. These findings highlight the versatility of 4-Bromo-2,6-difluorobenzonitrile as a pharmacophore in drug discovery.

Beyond pharmaceutical applications, 4-Bromo-2,6-difluorobenzonitrile finds utility in agrochemical research. Its structural features make it a suitable precursor for synthesizing novel pesticides and herbicides that target specific enzymatic pathways in pests while minimizing environmental impact. The< strong>fluoro-substituted benzonitrile derivatives derived from this compound have demonstrated enhanced efficacy against resistant strains of weeds and insects, underscoring their potential as next-generation crop protection agents.

The synthesis of 4-Bromo-2,6-difluorobenzonitrile typically involves multi-step organic transformations starting from commercially available precursors. Common synthetic routes include halogenation of fluorobenzonitriles followed by bromination at specific positions on the aromatic ring. Advances in catalytic methods have enabled more efficient and scalable production processes, reducing waste and improving yields. These innovations are essential for meeting the growing demand for this intermediate in industrial applications.

The safety profile of 4-Bromo-2,6-difluorobenzonitrile is another critical consideration in its handling and application. While it is not classified as a hazardous material under standard regulatory guidelines, proper precautions must be taken to prevent exposure during synthesis and handling. Personal protective equipment (PPE), including gloves and safety goggles, should be used to minimize risks. Additionally, good laboratory practices (GLP) must be followed to ensure safe storage and disposal.

In conclusion, 4-Bromo-2,6-difluorobenzonitrile (CAS No: 123843-67-4) is a versatile intermediate with significant applications in pharmaceuticals and agrochemicals. Its unique structural features make it an invaluable tool for medicinal chemists seeking to develop novel therapeutic agents targeting neurological and inflammatory disorders. The ongoing research into fluorinated aromatic nitriles continues to uncover new possibilities for this compound, reinforcing its importance in modern drug discovery.

• 916792-13-7(4-bromo-2-fluoro-5-methyl-benzonitrile)
• 133541-45-4(4-Bromo-2,5-difluorobenzonitrile)
• 1427438-75-2(4-Bromo-2-fluoro-6-methylbenzonitrile)
• 179897-89-3(5-Bromo-2-fluorobenzonitrile)
• 79544-27-7(2-Bromo-6-fluorobenzonitrile)
• 1105665-42-6(5-Bromo-2,3-difluorobenzonitrile)
• 105942-08-3(4-Bromo-2-fluorobenzonitrile)
• 17823-40-4(4-Bromo-2,3,5,6-tetrafluorobenzonitrile)
• 916792-07-9(2-Bromo-4-fluoro-5-methylbenzonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)